<p>Several new studies show that people who had even a mild coronavirus infection developed a lasting immunity to the virus.</p>
<p>The studies, none of which have yet been peer-reviewed, show that antibodies and immune cells known as B cells and T cells, which are able to recognize the SARS-CoV-2 virus, appear to be present months after infections have been cured.</p>
<p>One group of scientists &#8220;performed a longitudinal assessment of individuals recovered from mildly symptomatic COVID-19 to determine if they develop and sustain immunological memory against the virus,&#8221; their <a href="https://www.medrxiv.org/content/10.1101/2020.08.11.20171843v2">study</a> says. &#8220;We found that recovered individuals developed SARS-CoV-2-specific IgG antibody and neutralizing plasma, as well as virus-specific memory B and T cells that not only persisted, but in some cases increased numerically over three months following symptom onset.&#8221;</p>
<p>&#8220;Furthermore, the SARS-CoV-2-specific memory lymphocytes exhibited characteristics associated with potent antiviral immunity: memory T cells secreted IFN-γ and expanded upon antigen re-encounter, while memory B cells expressed receptors capable of neutralizing virus when expressed as antibodies. These findings demonstrate that mild COVID-19 elicits memory lymphocytes that persist and display functional hallmarks associated with antiviral protective immunity,&#8221; the scientists wrote.</p>
<p>“This is exactly what you would hope for,” Marion Pepper, an immunologist at the University of Washington who co-authored the study <a href="https://www.nytimes.com/2020/08/16/world/coronavirus-covid-19.html#link-2f7e6633">told</a> The New York Times. “All the pieces are there to have a totally protective immune response.”</p>
<p>Pepper said the next move will be more testing to find evidence that people are able to ward off the coronavirus after being exposed a second time, the paper reported.</p>
<p>“This is very promising,” Smita Iyer, an immunologist at the University of California, told the paper. “This calls for some optimism about herd immunity, and potentially a vaccine.”</p>
<p>Said the Times:</p>
<blockquote><p>Research on the coronavirus is proceeding so quickly, and in such volume, that the traditional review process often cannot keep pace. For the studies discussed here — as with un-peer-reviewed studies in general — The Times arranged for several experts to read and evaluate them.</p>
<p>Although researchers cannot forecast how long these immune responses will last, many experts consider the data a welcome indication that the body has a good chance of fending off the coronavirus if exposed to it again. “Things are really working as they’re supposed to,” said Deepta Bhattacharya, an immunologist at the University of Arizona and an author on one of the new <a class="css-1g7m0tk" title="" href="https://www.medrxiv.org/content/10.1101/2020.08.14.20174490v1" target="_blank" rel="noopener noreferrer">studies</a>, which has not yet been peer reviewed.</p></blockquote>
<p>The world’s largest COVID-19 vaccine study in the world began early this month, with the first of 30,000 Americans volunteering to take the shots. The experimental vaccine, developed by the National Institutes of Health (NIH) and Moderna Inc., is in phase three of the development process, which includes tests at clinical sites across the country.</p>
<p>“Having a safe and effective vaccine distributed by the end of 2020 is a stretch goal, but it’s the right goal for the American people,” NIH Director Dr. Francis Collins said in a <a href="https://www.nih.gov/news-events/news-releases/phase-3-clinical-trial-investigational-vaccine-covid-19-begins">statement</a>. “The launch of this phase-3 trial in record time while maintaining the most stringent safety measures demonstrates American ingenuity at its best and what can be done when stakeholders come together with unassailable objectivity toward a common goal.”</p>
<p><strong>Related: <a href="https://www.dailywire.com/news/russia-becomes-first-nation-to-approve-covid-19-vaccine">Russia Becomes First Nation To Approve COVID-19 Vaccine</a></strong></p>

<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
<script async src="https://www.tiktok.com/embed.js"></script>
<script async src="https://www.instagram.com/embed.js"></script><div data-widget-host="revcontent" data-pub-id="165152" data-widget-id="290588"></div><script src="https://delivery.revcontent.com/165152/290588/widget.js"></script>

Lasting Immunity Develops After Even Mild COVID-19 Infection, Studies Find

Vegas Family Claims Craft Crashed In Backyard, 9-Foot Aliens Emerged

Endless Pride: British Library Posts About Fish That Can Change Its Sex

Russia Taking Over Ukraine Not A ‘Top Foreign Policy Priority,’ GOP Presidential Candidate Says

America Has Spoken: There Are Two Genders. Period.

NY Times, WaPo Do Cartwheels To Spin Biden’s Clumsy Tumble; Twitterers Shred Them

Here’s The Weirdest Story You’ll Ever Read About Sen. Dianne Feinstein

News and Commentary

COVID

A video goes viral showing a baby being refused his mother by two gay "dads". This is just the tip of the iceberg, which is why we will have an important discussion today about surrogacy. 

Hour 1

The Matt Walsh Show

Ep. 1765 - This Video Is One Of The Worst Things I've Seen In A Long Time 

The Strait of Hormuz officially opens for business (kind of), the Pope makes “shocking” comments on immigration, and President Trump promises UFO disclosure at TPUSA. 


The Michael Knowles Show

Ep. 1956 -  Pope Leo's "SHOCKING" Immigration Comments EXPLAINED

A false miscreed has corrupted our leadership class.


The Andrew Klavan Show

Ep. 1275 - Dumb, Dumber and Progressive

President Trump announces a 10-day ceasefire between Lebanon and Israel, a murder-suicide involving former Democratic Lieutenant Governor Justin Fairfax shakes Virginia, and France and Britain hold a conference to secure the Strait of Hormuz – after the Iranian conflict ends. Get the facts first with Morning Wire.

- - -

Ep. 2738

- - -

Wake up with new Morning Wire merch: https://bit.ly/4lIubt3

- - -

Today's Sponsors:

Alliance Defending Freedom - Visit https://JoinADF.com/WIRE or text 'WIRE' to 83848 to learn more.

Pocket Hose - Text MORNING to 64000 to get a FREE pocket pivot and their 10-pattern sprayer with the purchase of ANY size Copper Head hose. Message and data rates may apply.

Morning Wire

U.S. Expands Hormuz Blockade & VA Fairfax Deaths Investigated | 4.17.26

U.S. Expands Hormuz Blockade & VA Fairfax Deaths Investigated | 4.17.26 [Member Exclusive]

A ceasefire goes into effect between Israel and Lebanon, a tragic murder-suicide rocks Virginia, and Dairy Queen deploys AI in the drive-thru. Get the facts first with Evening Wire.
- - -
Ep. 2737
- - -
Wake up with new Morning Wire merch: https://bit.ly/4lIubt3 
- - -
Today’s Sponsor:

Alliance Defending Freedom - Visit https://JoinADF.com/WIRE or text “WIRE” to 83848 to learn more.


Menu

— News and Commentary —

Lasting Immunity Develops After Even Mild COVID-19 Infection, Studies Find